ESMO Preceptorship on Brain Tumours 2022: Lugano
- Start date
- 23 Jun 2022
- End date
- 24 Jun 2022
- Location
- Lugano, Switzerland
Learning objectives
- To learn about the evidence base for diagnostic imaging, molecular pathology and neurocognitive assessment in brain tumor patients
- To understand the basis of multi-modality treatment of lower and higher-grade gliomas
- To learn about local and systemic treatment options for meningiomas
- To learn about the multi-modality management of brain metastasis patients including targeted therapies in patients with actionable driver mutations and with novel immunotherapies
- To learn about future developments in the management of gliomas, meningiomas, brain metastases and leptomeningeal carcinomatosis
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Giuseppe Minniti, Italy
- Michael Weller, Switzerland